D-Fenfluramine activates rat oxytocinergic and vasopressinergic neurons through different mechanisms

Brain Research

Volumn 851, Issue 1-2, 1999, Pages 247-251

  Mikkelsen, Jens D ^a   Jensen, Jens B ^a,b   Engelbrecht, Tine ^a   Mørk, Arne ^a  

^a H LUNDBECK A S   (Denmark)

^b BISPEBJERG HOSPITAL   (Denmark)

Author keywords

ACTH; Corticosterone; Fenfluramine; Paraventricular nucleus; Supraoptic nucleus

Indexed keywords

DEXFENFLURAMINE; OXYTOCIN; OXYTOCIN RECEPTOR; PROTEIN C FOS; SEROTONIN; VASOPRESSIN; VASOPRESSIN RECEPTOR;

ANIMAL EXPERIMENT; CONTROLLED STUDY; GENETIC TRANSCRIPTION; HORMONE RELEASE; IMMUNOCYTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONINERGIC TRANSMISSION; SHORT SURVEY; SUPRAOPTIC NUCLEUS; THALAMUS MIDLINE NUCLEUS;

EID: 0033373076     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)01953-8     Document Type: Article

References (17)

1. Bagdy G. Role of the hypothalamic paraventricular nucleus in 5-HT1A, 5-HT2A and 5-HT2C receptor-mediated oxytocin, prolactin and ACTH/corticosterone responses. Behav. Brain Res. 73:1996;277-280.
2. Duncan G.E., Knapp D.J., Carson S.W., Breese G.R. Differential effects of chronic antidepressant treatment on swim stress- and fluoxetine-induced secretion of corticosterone and progesterone. J. Pharmacol. Exp. Ther. 285:1998;579-587.
3. Guerra M.J., Liste I., Labandeira-Garcia J.L. Interaction between the serotonergic, dopaminergic, and glutamatergic systems in fenfluramine-induced Fos expression in striatal neurons. Synapse. 28:1998;71-82.
4. Iovino M., Steardo L. Effect of substances influencing brain serotonergic transmission on plasma vasopressin levels in the rat. Eur. J. Pharmacol. 113:1985;99-103.
5. Javed A., Kamradt M.C., van de Kar L.D., Gray T.S. D-Fenfluramine induces serotonin-mediated Fos expression in corticotrophin-releasing factor and oxytocin neurons of the hypothalamus, and serotonin-independent Fos expression in enkephalin and neurotensin neurons of the amygdala. Neuroscience. 90:1999;851-858.
6. Javed A., Van De Kar L.D., Gray T.S. p-Chlorophenylalanine and fluoxetine inhibit D-fenfluramine-induced Fos expression in the paraventricular nucleus, cingulate cortex and frontal cortex but not in other forebrain and brainstem regions. Brain Res. 774:1997;94-105.
7. Larsen P.J., Hay-Schmidt A., Vrang N., Mikkelsen J.D. Origin of projections from the midbrain raphe nuclei to the hypothalamic paraventricular nucleus in the rat: a combined retrograde and anterograde tracing study. Neuroscience. 70:1996;963-988.
8. Li B.H., Rowland N.E. Dexfenfluramine induces Fos-like immunoreactivity in discrete brain regions in rats. Brain Res. Bull. 31:1993;43-48.
9. Max J.P., Thystere P., Chapleur-Chateau M., Burlet A., Nicolas J.P., Burlet C. Hypothalamic neuropeptides could mediate the anorectic effects of fenfluramine. NeuroReport. 5:1994;1925-1928.
10. Richard D., Rivest S., Rivier C. The 5-hydroxytryptamine agonist fenfluramine increases Fos-like immunoreactivity in the brain. Brain Res. 594:1992;131-137.
11. Sawchenko P.E., Swanson L.W., Steinbusch H.W., Verhofstad A.A. The distribution and cells of origin of serotonergic inputs to the paraventricular and supraoptic nuclei of the rat. Brain Res. 277:1983;355-360.
12. Saydoff J.A., Rittenhouse P.A., Carnes M., Armstrong J., Van De Kar L.D., Brownfield M.S. Neuroendocrine and cardiovascular effects of serotonin: selective role of brain angiotensin on vasopressin. Am. J. Physiol. 270:1996;E513-E521.
13. Saydoff J.A., Rittenhouse P.A., van de Kar L.D., Brownfield M.S. Enhanced serotonergic transmission stimulates oxytocin secretion in conscious male rats. J. Pharmacol. Exp. Ther. 257:1991;95-99.
14. Van de Kar L.D., Levy A.D., Li Q., Brownfield M.S. A comparison of the oxytocin and vasopressin responses to the 5-HT1A agonist and potential anxiolytic drug alnespirone (S-20499). Pharmacol. Biochem. Behav. 60:1998;677-683.
15. Van de Kar L.D., Rittenhouse P.A., Li Q., Levy A.D., Brownfield M.S. Hypothalamic paraventricular, but not supraoptic neurons, mediate the serotonergic stimulation of oxytocin secretion. Brain Res. Bull. 36:1995;45-50.
16. Vicentic A., Li Q., Battaglia G., Van de Kar L.D. WAY-100635 inhibits 8-OH-DPAT-stimulated oxytocin, ACTH and corticosterone, but not prolactin secretion. Eur. J. Pharmacol. 346:1998;261-266.
17. Woldbye D.P., Greisen M.H., Bolwig T.G., Larsen P.J., Mikkelsen J.D. Prolonged induction of c-fos in neuropeptide Y- and somatostatin-immunoreactive neurons of the rat dentate gyrus after electroconvulsive stimulation. Brain Res. 720:1996;111-119.